Journal profile · Medicine, Research & Experimental
Advances in Experimental Medicine and Biology
ISSN 0065-2598 · eISSN 2214-8019 · Springer New York · UNITED STATES · Irregular · Founded 1967
Advances in Experimental Medicine and Biology: impact factor 2.15; subscription journal; review 2–4 weeks (community reports); 662 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Advances in Experimental Medicine and Biology is published by Springer New York. By OpenAlex counts of its recent articles, its largest topics are Immune Cell Function and Interaction, Neuroscience of respiration and sleep and T-cell and B-cell Immunology, together about 17.4% of its articles. Its main subfields are Immunology and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Advances in Experimental Medicine and Biology provides a platform for scientific contributions in the main disciplines of the biomedicine and the life sciences. This series publishes thematic volumes on contemporary research in the areas of microbiology, immunology, neurosciences, biochemistry, biomedical engineering, genetics, physiology, and cancer research. Covering emerging topics and techniques in basic and clinical science, it brings together clinicians and researchers from various fields.
From the journal's Aims & Scope
Research area (LetPub): Medicine, Research & Experimental
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Cell Function and InteractionImmunology and Microbiology6%
- Neuroscience of respiration and sleepNeuroscience5.9%
- T-cell and B-cell ImmunologyImmunology and Microbiology5.5%
- Neuroscience and Neuropharmacology ResearchNeuroscience5.3%
- Immunotherapy and Immune ResponsesImmunology and Microbiology5%
- Biochemical and Molecular ResearchBiochemistry, Genetics and Molecular Biology4.9%
- Aldose Reductase and TaurineBiochemistry, Genetics and Molecular Biology4.7%
- Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASzbMATHPublisher website
Other: EMBiology, Norwegian Register for Scientific Journals and Series, Pathway Studio, Reaxys, SCImago
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.15LetPub ·
- CiteScore 2026-06
- 3.4LetPub ·
- CiteScore (publisher) 2023
- 5.9Publisher website ·
- SJR 2026-06
- 0.49LetPub ·
- SNIP 2026-06
- 0.34LetPub ·
- h-index
- 107LetPub ·
- h-index
- 220OpenAlex ·
- i10-index
- 17,877OpenAlex ·
- 2-year mean citedness
- 2.35OpenAlex ·
- Share of gold OA articles
- 0.93%LetPub ·
Volume
- Articles per year
- 1,113LetPub ·
Articles by year OpenAlex count · 43,196 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 402 | 23 | 84 |
| 2025 | 662 | 55 | 1,107 |
| 2024 | 636 | 75 | 2,802 |
| 2023 | 793 | 88 | 3,958 |
| 2022 | 713 | 104 | 5,844 |
| 2021 | 1,352 | 133 | 18,162 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 2–4 weeksLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer New York
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Irregular
- Founded
- 1967
- ISSN
- 0065-2598
- Electronic ISSN
- 2214-8019
- Official links
- Journal homepage ↗LetPub
FAQ
Frequently asked questions about Advances in Experimental Medicine and Biology
What is the impact factor of Advances in Experimental Medicine and Biology?
The latest impact factor listed by LetPub is 2.15; CiteScore 3.4, h-index 220.
How long does peer review take at Advances in Experimental Medicine and Biology?
Authors report an average review time of 2–4 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Advances in Experimental Medicine and Biology?
According to LetPub and DOAJ records, Advances in Experimental Medicine and Biology is indexed in Scopus. The journal's website also lists MEDLINE, Embase, CAS and zbMATH; that list has not been checked against each database.
Is Advances in Experimental Medicine and Biology open access, and what is the APC?
Advances in Experimental Medicine and Biology is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .